GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
2,161
Funds Holding Change
+11
Funds Holding Growth
+0.5%
Value
$381B
Holding in Top 10
466
Top 10 Change
-32
Top 10 Growth
-6%
Value Growth
+4%
New
99
Increased
883
Reduced
1,009
Closed
67
Capital Inflow
$14.3B
Capital Outflow
$22.2B
Net Capital Flow
-$7.91B
Capital Flow Change
-$388B
Calls
$5.19B
Puts
$5.36B
Net Calls
-$171M
Put/Call Ratio
1.03